Term
|
Definition
| impairment of vision without a detectable lesion of the eye ("lazy eye") |
|
|
Term
|
Definition
|
|
Term
|
Definition
| buildup of fluid in the abdomen |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| premature contraction of the heart |
|
|
Term
|
Definition
| escape of fluid from a vessel into the surrounding tissue |
|
|
Term
|
Definition
| breast enlargement in males |
|
|
Term
|
Definition
|
|
Term
|
Definition
elevated serum potassium
-is a medical emergency that may result in arrhythmias |
|
|
Term
|
Definition
| excess uric acid in the blood- prerequesite for gout |
|
|
Term
|
Definition
|
|
Term
|
Definition
low serum potassium
2 presenting symptoms: weakness and leg cramps
can be prevented in some people by diet; others need supplements |
|
|
Term
|
Definition
| affecting the force of muscle contraction |
|
|
Term
|
Definition
| inadequate blood supply to a local area due to blockage of blood vessels to the area |
|
|
Term
|
Definition
| dark stool containing decomposing blood |
|
|
Term
|
Definition
|
|
Term
|
Definition
| excessive urination at night |
|
|
Term
|
Definition
| reduced excretion of urine |
|
|
Term
|
Definition
| a fall in blood pressure occurring on standing characterized by dizziness |
|
|
Term
|
Definition
| excessive excretion of urine |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| loss of consciousness (i.e. fainting) |
|
|
Term
|
Definition
|
|
Term
|
Definition
| visual disturbance in which objects appear yellow |
|
|
Term
|
Definition
|
|
Term
|
Definition
Capoten
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy
take on an empty stomach (aux label #2) |
|
|
Term
|
Definition
captopril
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy
take on an empty stomach (aux label #2) |
|
|
Term
|
Definition
Univasc
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy
take on an empty stomach (aux label #4) |
|
|
Term
|
Definition
moexipril
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy
take on an empty stomach (aux label #4) |
|
|
Term
|
Definition
Monopril
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy |
|
|
Term
|
Definition
fosinopril
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy |
|
|
Term
|
Definition
Accupril
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy |
|
|
Term
|
Definition
quinapril
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy |
|
|
Term
|
Definition
Mavik
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy |
|
|
Term
|
Definition
trandolapril
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy |
|
|
Term
|
Definition
Vasotec
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy |
|
|
Term
|
Definition
enalapril
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy |
|
|
Term
|
Definition
Prinivil, Zestril
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy |
|
|
Term
|
Definition
lisinopril
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy |
|
|
Term
|
Definition
lisinopril
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy |
|
|
Term
|
Definition
Lotensin
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy |
|
|
Term
|
Definition
benazepril
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy |
|
|
Term
|
Definition
Aceon
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy |
|
|
Term
|
Definition
perindopril
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy |
|
|
Term
|
Definition
Altace
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy |
|
|
Term
|
Definition
ramipril
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy |
|
|
Term
lisinopril
hydrochlorothiazide (hctz) |
|
Definition
no trade name
hctz- thiazide diuretic
lisinopril-
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy |
|
|
Term
captopril
hydrochlorothiazide (hctz) |
|
Definition
no trade name
hctz- thiazide diuretic
captopril-
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy |
|
|
Term
enalapril
hydrochlorothiazide (hctz) |
|
Definition
no trade name
hctz- thiazide diuretic
enalapril-
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy |
|
|
Term
quinapril
hydrochlorothiazide (hctz) |
|
Definition
Accuretic
hctz- thiazide diuretic
quinapril-
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy |
|
|
Term
|
Definition
hctz- thiazide diuretic
quinapril-
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy |
|
|
Term
fosinopril
hydrochlorothiazide (hctz) |
|
Definition
Monopril HCT
hctz- thiazide diuretic
fosinopril-
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy |
|
|
Term
|
Definition
hctz- thiazide diuretic
fosinipril-
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy |
|
|
Term
benazepril
hydrochlorothiazide (hctz) |
|
Definition
Lotensin HCT
hctz- thiazide diuretic
benazepril-
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy |
|
|
Term
|
Definition
hctz- thiazide diuretic
benazepril-
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy |
|
|
Term
moexipril
hydrochlorothiazide (hctz) |
|
Definition
Uniretic
hctz- thiazide diuretic
moexipril-
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy |
|
|
Term
|
Definition
hctz- thiazide diuretic
moexipril-
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy |
|
|
Term
|
Definition
Lotrel
ind. hypertension
cap
once daily
amlodipine- Ca Channel Blocker (dihydropyridine)
benazepril-
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy |
|
|
Term
|
Definition
ind. hypertension
cap
once daily
amlodipine- Ca Channel Blocker (dihydropyridine)
benazepril-
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy |
|
|
Term
|
Definition
Tarka
verapamil- Ca Channel Blocker (phenylalkylamine)
trandolapril-
ACE Inhibitor
ind. treatment of hypertension and heart failure
angiotensin converting enzyme (ACE) inhibitors prevent the conversion of angiotensin I (inactive) to angiotensin II (vasoconstrictor)
side effect: hyperkalemia may occur thus potassium replacement products and potassium sparing diuretics (spironolactone- Aldactone; triamterene- Dyrenium; amiloride) should be prescribed cautiously
counsel: don't use salt substitutes containing K
contraindicated in pregnancy |
|
|
Term
|
Definition
Teveten
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
|
Definition
eprosartan
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
|
Definition
Micardis
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
tab (20mg, 40mg, 80mg)
once daily
ARBs: prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
|
Definition
telmisartan
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
tab (20mg, 40mg, 80mg)
once daily
ARBs: prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
|
Definition
Atacand
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
tab (4mg, 8mg, 16mg, 32mg)
once daily
ARBs: prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
|
Definition
Avapro
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
tab (75mg, 150mg, 300mg)
once daily
ARBs: prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
|
Definition
candesartan
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
tab (4mg, 8mg, 16mg, 32mg)
once daily
ARBs: prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
|
Definition
irbesartan
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
tab (75mg, 150mg, 300mg)
once daily
ARBs: prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
|
Definition
Diovan
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
tab (40mg, 80mg, 160mg, 320mg)
once daily
ARBs: prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
|
Definition
valsartan
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
tab (40mg, 80mg, 160mg, 320mg)
once daily
ARBs: prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
|
Definition
Edarbi
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
|
Definition
azilsartan
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
|
Definition
Cozaar
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
|
Definition
losartan
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
|
Definition
Benicar
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
tab (5mg, 20mg, 40mg)
once daily
ARBs: prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
|
Definition
olmesartan
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
tab (5mg, 20mg, 40mg)
once daily
ARBs :prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
irbesartan
hydrochlorothiazide (hctz) |
|
Definition
Avalide
hctz- thiazide diuretic
irbesartan-
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
|
Definition
hctz- thiazide diuretic
irbesartan-
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
losartan
hydrochlorothiazide (hctz)
|
|
Definition
Hyzaar
ind. hypertension
tab
once daily
hctz- thiazide diuretic
losartan-
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
|
Definition
ind. hypertension
tab
once daily
hctz- thiazide diuretic
losartan-
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
telmisartan
hydrochlorothiazide |
|
Definition
Micardis HCT
ind. hypertension
tab
once daily
hctz- thiazide diuretic
telmisartan-
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
|
Definition
ind. hypertension
tab
once daily
hctz- thiazide diuretic
telmisartan-
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
candesartan
hydrochlorthiazide |
|
Definition
Atacand HCT
hctz- thiazide diuretic
candesartan-
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
|
Definition
hctz- thiazide diuretic
candesartan-
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
|
Definition
Azor
ind. hypertension
tab
once daily
amlodipine- Ca Channel Blocker (dihydropyridine)
olmesartan-
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
|
Definition
ind. hypertension
tab
once daily
amlodipine- Ca Channel Blocker (dihydropyridine)
olmesartan-
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
eprosartan
hydrochlorothiazide (hctz) |
|
Definition
Teveten HCT
hctz- thiazide diuretic
eprosartan-
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
|
Definition
hctz- thiazide diuretic
eprosartan-
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
valsartan
hydrochlorothiazide (hctz) |
|
Definition
Diovan HCT
ind. hypertension
tab
once daily
hctz- thiazide diuretic
valsartan-
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
tab
once daily
prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
|
Definition
hctz- thiazide diuretic
ind. hypertension
tab
once daily
valsartan-
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
olmesartan
hydrochlorothiazide (hctz) |
|
Definition
Benicar HCT
ind. hypertension
tab
once daily
hctz- thiazide diuretic
olmesartan-
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
|
Definition
ind. hypertension
tab
once daily
hctz- thiazide diuretic
olmesartan-
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
|
Definition
Exforge
ind. hypertension
tab
once daily
amlodipine- Ca Channel Blocker (dihydropyridine)
valsartan-
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
|
Definition
ind. hypertension
tab
once daily
amlodipine- Ca Channel Blocker (dihydropyridine)
valsartan-
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
|
Definition
Valturna
aliskiren- direct renin inhibitor (inhibiting renin prevents converstion of angiotensinogen to angiotensin I- and ultimately angiotensin II)
valsartan-
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
|
Definition
aliskiren- direct renin inhibitor (inhibiting renin prevents converstion of angiotensinogen to angiotensin I- and ultimately angiotensin II)
valsartan-
Angiotensin II Receptor Antagonist (ARB)
ind. hypertension
prevents angiotensin II from exerting vasoconstrictor effects by blocking angiotensin II receptor sites; production of angiotensin II is not affected
side effect: hyperkalemia; thus, potassium replacement products and potassium-sparing diuretics should be prescribed cautiously
counsel: do not use salt substitutes containing K
contradindicated in pregancy |
|
|
Term
|
Definition
Aldactone
postassium- sparing diuretic
prescribe cautiously with ACE inhibitors and ARBs
aux label #10 |
|
|
Term
|
Definition
spironolactone
postassium- sparing diuretic
prescribe cautiously with ACE inhibitors and ARBs
aux label #10 |
|
|
Term
|
Definition
Dyrenium
postassium- sparing diuretic
prescribe cautiously with ACE inhibitors and ARBs |
|
|
Term
|
Definition
no trade name
postassium- sparing diuretic
prescribe cautiously with ACE inhibitors and ARBs |
|
|
Term
|
Definition
Tekturna
renin inhibitor (inhibiting renin prevents converstion of angiotensinogen to angiotensin I- and ultimately angiotensin II)
ind. hypertension
tab (150mg, 300mg)
once daily
aux label #2 |
|
|
Term
|
Definition
aliskiren
renin inhibitor (inhibiting renin prevents converstion of angiotensinogen to angiotensin I- and ultimately angiotensin II)
ind. hypertension
tab (150mg, 300mg)
once daily
aux label #2 |
|
|
Term
|
Definition
aliskiren- renin inhibitor
hctz- thiazide diuretic |
|
|
Term
aliskiren
hydrochlorothiazide (hctz) |
|
Definition
aliskiren- renin inhibitor
hctz- thiazide diuretic |
|
|
Term
|
Definition
inhibit calcium ion entry into cardiac and vascular smooth muscle
this produces a relaxation (dilation) of vascular smooth muscle
calcium channel blocking agents are ind. for treatment of hypertension; sometimes prescribed for migraine prophylaxis (off-label use)
3 classes:
dihydropyridines
benzothiazepines
phenylalkylamines |
|
|
Term
|
Definition
Cardizem LA
Ca Channel Blocker
benzothiazepine
ind. hypertension
ER tab
once daily |
|
|
Term
|
Definition
diltiazem
Ca Channel Blocker
benzothiazepine
ind. hypertension
ER tab
once daily |
|
|
Term
|
Definition
Sular
Ca Channel Blocker
dihydropyridine
ind. hypertension
ER tab (8.5mg, 17mg, 25.5mg, 34mg)
once daily |
|
|
Term
|
Definition
nisoldipine
Ca Channel Blocker
dihydropyridine
ind. hypertension
ER tab (8.5mg, 17mg, 25.5mg, 34mg)
once daily |
|
|
Term
|
Definition
Caduet
ind. hypertension & hyperlipidemia
tab
once daily
amlodipine- Ca Channel Blocker (dihydropyridine)
atorvastatin- HMG-CoA Reductase Inhibitor |
|
|
Term
|
Definition
ind. hypertension & hyperlipidemia
tab
once daily
amlodipine- Ca Channel Blocker (dihydropyridine)
atorvastatin- HMG-CoA Reductase Inhibitor |
|
|
Term
|
Definition
Dynacirc CR
Ca Channel Blocker
dihydropyridine |
|
|
Term
|
Definition
isradipine
Ca channel blocker
dihydropyridine |
|
|
Term
|
Definition
no trade name
Ca Channel Blocker
dihydropyridine |
|
|
Term
|
Definition
Adalat CC, Procardia XL
Ca channel Blocker
dihydropyridine |
|
|
Term
|
Definition
nifedipine
Ca channel blocker
dihydropyridine |
|
|
Term
|
Definition
nifedipine
Ca Channel Blocker
dihydropyridine |
|
|
Term
|
Definition
Cardene SR
Ca Channel Blocker
dihydropyridine |
|
|
Term
|
Definition
nicardipine
Ca channel blocker
dihydropyridine |
|
|
Term
|
Definition
Norvasc
Ca channel Blocker
dihydropyridine |
|
|
Term
|
Definition
amlodipine
Ca channel Blocker
dihydropyridine |
|
|
Term
|
Definition
Calan, Verelan PM
Ca Channel Blocker
phenylalkylamine |
|
|
Term
|
Definition
verapamil
Ca Channel Blocker
phenylalkylamine |
|
|
Term
|
Definition
verapamil
Ca Channel Blocker
phenylalkylamine |
|
|
Term
|
Definition
verapamil- Ca Channel Blocker (phenylalkylamine)
trandolapril-
ACE Inhibitor
|
|
|
Term
| Alpha-1 Adrenergic Blocking Agents |
|
Definition
ind. for hypertension, symptoms of benign prostatic hyperplasia (BPH) or both
Men with BPH often have urinary outflow obstruction due to inc. smooth muscle tone of the bladder neck. These medications improve urinary outflow by relaxing smooth muscle in the bladder neck.
these drugs may cause marekd hypotension, esp. in the upright position, with dizziness and syncope; this is most common with the first dose but can also occur with a dosage increase or if therapy is interrupted and begun again; to dec. these effects,
take at bedtime and inc. dose slowly as needed |
|
|
Term
|
Definition
Flomax
Alpha-1 Adrenergic Blocking Agent
ind. symptoms of BPH
cap (0.4mg)
once daily |
|
|
Term
|
Definition
tamsulosin
Alpha-1 Adrenergic Blocking Agent
ind. symptoms of BPH
cap (0.4mg)
once daily |
|
|
Term
|
Definition
Uroxatral
Alpha-1 Adrenergic Blocking Agent
ind. symptoms of BPH
ER tab (10mg)
once daily |
|
|
Term
|
Definition
alfuzosin
Alpha-1 Adrenergic Blocking Agent
ind. symptoms of BPH
ER tab (10mg)
once daily |
|
|
Term
|
Definition
Cardura, Cardura XL
Alpha-1 Adrenergic Blocking Agent
ind. hypertension & symptoms of BPH
|
|
|
Term
|
Definition
doxazosin
Alpha-1 Adrenergic Blocking Agent
ind. hypertension & symptoms of BPH
|
|
|
Term
|
Definition
doxazosin
Alpha-1 Adrenergic Blocking Agent
ind. hypertension & symptoms of BPH
|
|
|
Term
|
Definition
no trade name
Alpha-1 Adrenergic Blocking Agent
ind. hypertension & symptoms of BPH
|
|
|
Term
|
Definition
Minipress
Alpha-1 Adrenergic Blocking Agent
ind. hypertension
|
|
|
Term
|
Definition
prazosin
Alpha-1 Adrenergic Blocking Agent
ind. hypertension
|
|
|
Term
|
Definition
Rapaflo
Alpha-1 Adrenergic Blocking Agent
ind. symptoms of BPH
|
|
|
Term
|
Definition
silodosin
Alpha-1 Adrenergic Blocking Agent
ind. symptoms of BPH
|
|
|
Term
| Beta-adrenergic receptor antagonists |
|
Definition
aka Beta Blockers
ind. hypertension, angina pectoris, and certain arrhythmias |
|
|
Term
|
Definition
Toprol XL
Beta-Adrenergic Blocking Agent
ind. hypertension, angina pectoris
ER tab (25mg, 50mg, 100mg, 200mg)
once daily |
|
|
Term
|
Definition
metoprolol succinate
Beta-Adrenergic Blocking Agent
ind. hypertension, angina pectoris
ER tab (25mg, 50mg, 100mg, 200mg)
once daily |
|
|
Term
|
Definition
Lopressor
Beta-Adrenergic Blocking Agent
ind. hypertension, angina pectoris
IR tab (25mg, 50mg, 100mg)
twice daily |
|
|
Term
|
Definition
metoprolol tartrate
Beta-Adrenergic Blocking Agent
ind. hypertension, angina pectoris
IR tab (25mg, 50mg, 100mg)
twice daily |
|
|
Term
|
Definition
Coreg, Coreg CR
Beta-Adrenergic Blocking Agent
ind. hypertension, heart failure
Coreg- tab (3.125mg, 6.25mg, 12.5mg, 25mg)
twice daily
Coreg- ER cap (10mg, 20mg, 40mg, 80mg)
once daily
aux label #4 (slows absorption and reduces incidence of orhtostatic hypotension) |
|
|
Term
|
Definition
carvedilol
Beta-Adrenergic Blocking Agent
ind. hypertension, heart failure
tab (3.125mg, 6.35mg, 12.5mg, 25mg)
twice daily
aux label #4 (slows absorption and reduces incidence of orhtostatic hypotension) |
|
|
Term
|
Definition
carvedilol
Beta-Adrenergic Blocking Agent
ind. hypertension, heart failure
ER cap (10mg, 20mg, 40mg, 80mg)
once daily
aux label #4 (slows absorption and reduces incidence of orhtostatic hypotension) |
|
|
Term
|
Definition
Inderal LA
Beta-Adrenergic Blocking Agent
ind. hypertension, angina pectoris, migraine prophylaxis
ER cap (60mg, 80mg, 120mg, 160mg)
once daily |
|
|
Term
|
Definition
propranolol
Beta-Adrenergic Blocking Agent
ind. hypertension, angina pectoris, migraine prophylaxis
ER cap (60mg, 80mg, 120mg, 160mg)
once daily |
|
|
Term
|
Definition
Bystolic
Beta-Adrenergic Blocking Agent
ind. hypertension
tab (2.5mg, 5mg, 10mg)
once daily |
|
|
Term
|
Definition
nebivolol
Beta-Adrenergic Blocking Agent
ind. hypertension
tab (2.5mg, 5mg, 10mg)
once daily |
|
|
Term
|
Definition
no trade name
Beta-Adrenergic Blocking Agent |
|
|
Term
|
Definition
Tenormin
Beta-Adrenergic Blocking Agent |
|
|
Term
|
Definition
atenolol
Beta-Adrenergic Blocking Agent |
|
|
Term
|
Definition
Betapace
Beta-Adrenergic Blocking Agent |
|
|
Term
|
Definition
sotalol
Beta-Adrenergic Blocking Agent |
|
|
Term
|
Definition
Corgard
Beta-Adrenergic Blocking Agent |
|
|
Term
|
Definition
nadolol
Beta-Adrenergic Blocking Agent |
|
|
Term
|
Definition
Zebeta
Beta-Adrenergic Blocking Agent |
|
|
Term
|
Definition
bisoprolol
Beta-Adrenergic Blocking Agent |
|
|
Term
|
Definition
Tenoretic
atenolol- Beta-Adrenergic Blocking Agent
chlorthalidone- diuretic |
|
|
Term
|
Definition
atenolol- Beta-Adrenergic Blocking Agent
chlorthalidone- diuretic |
|
|
Term
nadolol
hydrochlorothiazide (hctz) |
|
Definition
Corzide
nadolol- Beta-Adrenergic Blocking Agent
hctz- thiazide diuretic |
|
|
Term
|
Definition
nadolol- Beta-Adrenergic Blocking Agent
hctz- thiazide diuretic |
|
|
Term
bisoprolol
hydrochlorothiazide (hctz) |
|
Definition
Ziac
bisoprolol- Beta-Adrenergic Blocking Agent
hctz- thiazide diuretic
|
|
|
Term
|
Definition
bisoprolol- Beta-Adrenergic Blocking Agent
hctz- thiazide diuretic |
|
|
Term
|
Definition
Catapres-TTS
Antihypertensive (Alpha-2 Adrenergic Agonist)
ind. hypertension
transdermal (0.1mg/24hrs; 0.2mg/24hrs; 0.3mg/24hrs)
once weekly |
|
|
Term
|
Definition
clonidine
Antihypertensive (Alpha-2 Adrenergic Agonist)
ind. hypertension
transdermal (0.1mg/24hrs; 0.2mg/24hrs; 0.3mg/24hrs)
once weekly |
|
|
Term
|
Definition
Lanoxin (and no trade)
Cardiac Glycoside
ind. heart failure
Lanoxin- tab (0.125mg, 0.25mg)
no trade- oral solution (0.05mg/mL)
no trade- injection (0.25mg/mL)
once daily
normal digoxin serum level for treatment of heart failure is:
0.5-0.8 ng/mL
normal digoxin serum level for treatment of arrhythmias is:
0.8-2 ng/mL
-this drug exerts a positive inotropic action (increases the force of myocardial contractions)
-K depleting diuretics (thiazide and loop diuretics) should be used cautiously while taking digoxin b/c hypokalemia inc. risk of digoxin toxicity
signs of digoxin toxicity: nausea&vomiting, visual disturbances and arrhythmias |
|
|
Term
| digoxin immune fab (ovine) |
|
Definition
Digibind
antidote for digoxin toxicity
drug is antigen binding fragments (fab) derived from specific antidigoxin antibodies produced in sheep.
ovine means pertaining to or derived from sheep
administered intravenously |
|
|
Term
| digoxin immune fab (ovine) |
|
Definition
Digibind
antidote for digoxin toxicity
drug is antigen binding fragments (fab) derived from specific antidigoxin antibodies produced in sheep.
ovine means pertaining to or derived from sheep
administered intravenously |
|
|
Term
|
Definition
Lasix
Loop Diuretic
ind. hypertension, edema
tab (20mg, 40mg, 80mg)
oral solution (10mg/mL)
once daily
aux label #9, 10 |
|
|
Term
|
Definition
furosemide
Loop Diuretic
ind. hypertension, edema
tab (20mg, 40mg, 80mg)
oral solution (10mg/mL)
once daily
aux label #9, 10 |
|
|
Term
|
Definition
are K depleting
include furosemide (Lasix)
bumetanide
ethacrynic acid (Edecrin)
torsemide (Demadex)
-administer these early in the day to avoid nocturia |
|
|
Term
|
Definition
Loop Diuretic
aux label #9, 10 |
|
|
Term
|
Definition
Edecrin
Loop Diuretic
aux label #9, 10 |
|
|
Term
|
Definition
ethacrynic acid
Loop Diuretic
aux label #9, 10 |
|
|
Term
|
Definition
Demadex
Loop Diuretic
aux label #9, 10 |
|
|
Term
|
Definition
torsemide
Loop Diuretic
aux label #9, 10 |
|
|
Term
triamterene
hydrochlorothiazide (hctz) |
|
Definition
Dyazide, Maxzide
triamterene- K-Sparing Diuretic
hctz- Thiazide Diuretic
ind. hypertension, edema
cap (37.5mg triamterene; 25mg hctz)
once daily
pts taking should not experience any change in serum K level. |
|
|
Term
|
Definition
triamterene- K-Sparing Diuretic
triamterene- K-Sparing Diuretic
hctz- Thiazide Diuretic
ind. hypertension, edema
cap (37.5mg triamterene; 25mg hctz)
once daily
pts taking should not experience any change in serum K level. |
|
|
Term
|
Definition
K-Sparing Diuretic
aux label #9, 10 |
|
|
Term
|
Definition
Zaroxolyn
K-Sparing Diuretic
aux label #9, 10 |
|
|
Term
|
Definition
metolazone
K-Sparing Diuretic
aux label #9, 10 |
|
|
Term
|
Definition
K-Sparing Diuretic
aux label #9, 10 |
|
|
Term
|
Definition
Klor-Con, Klor-Con M
Potassium Replacement Product
ind. hypokalemia
ER tab: Klor-Con (8mEq, 10mEq)
Klor-Con M (10mEq, 15mEq, 20mEq)
variable
8mEq=600mg
10mEq=750mg
15mEq=1125mg
20mEq=1500mg
Klor-Con M tabs contain microencapsulated KCl
Klor-Con tabs contain KCl in a wax matrix
These formulations slow the release of K from the tab reducing the likelihood of high localized K concentration in the GI tract (aka reduces ulcerogenic tendency)
normal serum level K level is 3.5-5mEq/L |
|
|
Term
|
Definition
potassium chloride
Potassium Replacement Product
ind. hypokalemia
ER tab: Klor-Con (8mEq, 10mEq)
variable
8mEq=600mg
10mEq=750mg
Klor-Con tabs contain KCl in a wax matrix
These formulations slow the release of K from the tab reducing the likelihood of high localized K concentration in the GI tract (aka reduces ulcerogenic tendency)
normal serum level K level is 3.5-5mEq/L |
|
|
Term
|
Definition
potassium chloride
Potassium Replacement Product
ind. hypokalemia
ER tab: Klor-Con M (10mEq, 15mEq, 20mEq)
variable
10mEq=750mg
15mEq=1125mg
20mEq=1500mg
Klor-Con M tabs contain microencapsulated KCl
This formulation slows the release of K from the tab reducing the likelihood of high localized K concentration in the GI tract (aka reduces ulcerogenic tendency)
normal serum level K level is 3.5-5mEq/L |
|
|
Term
| sodium polystyrene sulfonate |
|
Definition
SPS, Kayexalate
is a cation exchange resin
-once gets into intestine, Na ions in resin are exchanged for K and then resin is excreted with stool
oral medication utilized to rapidly lower K level
SPS: ready to use oral suspension
Kayexalate: powder |
|
|
Term
|
Definition
sodium polystyrene sulfonate
is a cation exchange resin
-once gets into intestine, Na ions in resin are exchanged for K and then resin is excreted with stool
oral medication utilized to rapidly lower K level
SPS: ready to use oral suspension
Kayexalate: powder |
|
|
Term
|
Definition
sodium polystyrene sulfonate
is a cation exchange resin
-once gets into intestine, Na ions in resin are exchanged for K and then resin is excreted with stool
oral medication utilized to rapidly lower K level
SPS: ready to use oral suspension
Kayexalate: powder |
|
|
Term
|
Definition
Plavix
Antiplatelet Agent (reduces platelet aggregation)
ind. reduction of thrombotic events (i.e. myocardial infarction, stroke)
tab (75mg, 300mg)
once daily
|
|
|
Term
|
Definition
clopidogrel
Antiplatelet Agent (reduces platelet aggregation)
ind. reduction of thrombotic events (i.e. myocardial infarction, stroke)
tab (75mg, 300mg)
once daily
|
|
|
Term
|
Definition
no trade name
Antiplatelet Agent
tab (250mg)
twice daily
aux label #4 |
|
|
Term
|
Definition
Pletal
Antiplatelet Agent
tab (50mg, 100mg)
twice daily
aux label #2 (taking with food, may inc. cilostazol blood levels with a consequent inc. in adverse effects) |
|
|
Term
|
Definition
cilostazol
Antiplatelet Agent
tab (50mg, 100mg)
twice daily
aux label #2 (taking with food, may inc. cilostazol blood levels with a consequent inc. in adverse effects) |
|
|
Term
|
Definition
Effient
Antiplatelet Agent
tab (5mg, 10mg)
once daily |
|
|
Term
|
Definition
prasugrel
Antiplatelet Agent
tab (5mg, 10mg)
once daily |
|
|
Term
|
Definition
Aggrenox
Antiplatelet Agent
ind. reduction of thrombotic events
variable-release cap (200mg dipyridamole; 25mg aspirin)
twice daily
-both drugs can inhibit platelet aggregation |
|
|
Term
|
Definition
dipyridamole; aspirin
Antiplatelet Agent
ind. reduction of thrombotic events
variable-release cap (200mg dipyridamole; 25mg aspirin)
twice daily
-both drugs can inhibit platelet aggregation |
|
|
Term
|
Definition
Niaspan
Antihyperlipidemic
ind. niacin deficiency, hyperlipidemia
ER tab (500mg, 750mg, 1000mg)
once daily
side effect: niacin causes flushing; effect can be reduced by taking a 325mg aspirin or a 200mg ibuprofen 30 min before taking niacin |
|
|
Term
|
Definition
niacin
Antihyperlipidemic
ind. niacin deficiency, hyperlipidemia
ER tab (500mg, 750mg, 1000mg)
once daily
side effect: niacin causes flushing; effect can be reduced by taking a 325mg aspirin or a 200mg ibuprofen 30 min before taking niacin |
|
|
Term
Vitamin B's
B1
B2
B3
B6
B9
B12 |
|
Definition
B1- thiamin
B2- riboflavin
B3- niacin, nicotinic acid
B6- pyridoxine
B9- folic acid
B12- cyanocobalamin |
|
|
Term
|
Definition
Nitrostat, Nitrolingual, Nitro-Dur, Minitran, no trade, Nitro-Bid
Vasodilator
ind. treatment and prevention of angina pectoris
Nitrostat: sublingual tab
ind. relieves acute angina attacks
0.3mg (1/200grain), 0.4mg (1/150 grain), 0.6mg (1/100grain)
-loss of potency through volatilization of nitroglycerin is accelerated by exposure to moisture; after bottle is opened, subtabs will maintain potency through expiration date provided the cap is replaced tightly
-some pts replace bottle q 6 months to ensure potency
-USP requires sublingual form is dispensed in original unopened manufactuer's glass container (bottles of 25 and 100 ts are available)
when placed in rx vial for labeling, a child-resistant cap should not be used
Nitrolingual- translingual spray
is a metered dose aerosol
ind. angina pectoris (will relieve an acute angina attack)
each spray deliver 0.4mg nitroglycerin
counsel: administer the spray under the tongue
Nitro-Dur, Minitran- transdermal delivery system
will not relieve an acute angina attack
only ind for prevention
available in several release rates
no trade- sustained release cap
will not relieve an acute angina attack
only ind. for prevention
2.5mg, 6.5mg, 9mg
Nitro-Bid- topical ointment
2% strength
only ind. for prevention |
|
|
Term
|
Definition
nitroglycerin
Vasodilator
ind. treatment and prevention of angina pectoris
Nitrostat: sublingual tab
ind. relieves acute angina attacks
0.3mg (1/200grain), 0.4mg (1/150 grain), 0.6mg (1/100grain)
-loss of potency through volatilization of nitroglycerin is accelerated by exposure to moisture; after bottle is opened, subtabs will maintain potency through expiration date provided the cap is replaced tightly
-some pts replace bottle q 6 months to ensure potency
-USP requires sublingual form is dispensed in original unopened manufactuer's glass container (bottles of 25 and 100 ts are available)
when placed in rx vial for labeling, a child-resistant cap should not be used
|
|
|
Term
|
Definition
nitroglycerin
Vasodilator
ind. treatment and prevention of angina pectoris
Nitrolingual- translingual spray
is a metered dose aerosol
ind. angina pectoris (will relieve an acute angina attack)
each spray deliver 0.4mg nitroglycerin
counsel: administer the spray under the tongue |
|
|
Term
|
Definition
nitroglycerin
Vasodilator
ind. prevention of angina pectoris
Nitro-Dur- transdermal delivery system
only ind for prevention
available in several release rates
|
|
|
Term
|
Definition
nitroglycerin
Vasodilator
ind. prevention of angina pectoris
Minitran- transdermal delivery system
will not relieve an acute angina attack
only ind for prevention
available in several release rates
|
|
|
Term
|
Definition
Vasodilator
ind. prevention of angina pectoris
no trade- sustained release cap
will not relieve an acute angina attack
only ind. for prevention
2.5mg, 6.5mg, 9mg
|
|
|
Term
|
Definition
nitroglycerin
Vasodilator
ind. prevention of angina pectoris
Nitro-Bid- topical ointment
2% strength
only ind. for prevention |
|
|
Term
|
Definition
vasodilator
ind. prevention of angina pectoris
relief of pain, dysphagia and esophageal spasms associated with gastoesophageal reflux disease |
|
|
Term
|
Definition
Imdur, Ismo, Monoket
vasodilator
ind. prevention of angina pectoris
relief of pain, dysphagia and esophageal spasms associated with gastoesophageal reflux disease
Imdur- ER tab; once daily
Ismo, Monoket- tab; twice daily, 7 hrs apart (to minimize nitrate tolerance)
isosorbide mononitrate is the active metabolite of isosorbide dinitrate |
|
|
Term
|
Definition
isosorbide mononitrate
vasodilator
ind. prevention of angina pectoris
relief of pain, dysphagia and esophageal spasms associated with gastoesophageal reflux disease
Imdur- ER tab; once daily
isosorbide mononitrate is the active metabolite of isosorbide dinitrate |
|
|
Term
|
Definition
isosorbide mononitrate
vasodilator
ind. prevention of angina pectoris
relief of pain, dysphagia and esophageal spasms associated with gastoesophageal reflux disease
Ismo- tab; twice daily, 7 hrs apart (to minimize nitrate tolerance)
isosorbide mononitrate is the active metabolite of isosorbide dinitrate |
|
|
Term
|
Definition
isosorbide mononitrate
vasodilator
ind. prevention of angina pectoris
relief of pain, dysphagia and esophageal spasms associated with gastoesophageal reflux disease
Monoket- tab; twice daily, 7 hrs apart (to minimize nitrate tolerance)
isosorbide mononitrate is the active metabolite of isosorbide dinitrate |
|
|
Term
| hydrochlorothiazide (hctz) |
|
Definition
thiazide diuretic
aux lable #9, 10 |
|
|
Term
|
Definition
triamterene- K-Sparing Diuretic
triamterene- K-Sparing Diuretic
hctz- Thiazide Diuretic
ind. hypertension, edema
cap (37.5mg triamterene; 25mg hctz)
once daily
pts taking should not experience any change in serum K level.
|
|
|
Term
amiloride
hydrochlorothiazide (hctz) |
|
Definition
no trade name
amiloride: postassium- sparing diuretic
hctz: thiazide diuretic |
|
|
Term
|
Definition
triamterene
postassium- sparing diuretic
prescribe cautiously with ACE inhibitors and ARBs |
|
|
